RVNC
$25.57
Revance Therapeutics
($.61)
(2.33%)
RVNC
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($1.00)
Revenue:  $1.05 Mil
Thursday
Aug 6
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RVNC reports earnings?
Beat
Meet
Miss

Where is RVNC's stock price going from here?
Up
Flat
Down
Stock chart of RVNC
Analysts
Summary of analysts' recommendations for RVNC
Score
Grade
Pivots
Resistance
$27.01
$26.58
$26.07

$25.64

Support
$25.13
$24.70
$24.19
Tweet
Growth
Peers
Regeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalInterCeptJohnson & JohnsonZoetisUltragenyx PharmaceuticalMylanBristol-Myers SquibbCatalent